ISRG vs. MDT: Which Surgical Robot Stock Looks Like the Stronger Buy Now?

Intuitive Surgical (ISRG) and Medtronic (MDT) are two major names in medical technology, but their positions in surgical robotics are very different. Intuitive Surgical remains the clear leader through its da Vinci robotic surgery platform, while Medtronic is still building momentum with its Hugo robotic-assisted surgery system.

Why Surgical Robotics Matters

Surgical robotics is one of the most important growth areas in healthcare. Hospitals are using robotic systems to support minimally invasive procedures, improve surgeon control, and increase operating-room efficiency. Intuitive’s da Vinci 5 platform includes more than 150 design innovations and far higher computing power than earlier systems, according to the company.

Medtronic’s Hugo system also targets robotic-assisted surgery and is supported by its Touch Surgery ecosystem, which uses data, video, and analytics to help surgical teams review performance and improve workflows.

ISRG Has the Stronger Growth Story

Intuitive Surgical continues to benefit from a large installed base, recurring revenue from instruments and services, and rising global procedure volumes. Recent market coverage noted that Intuitive’s da Vinci procedures increased strongly in early 2026, helping support the company’s growth outlook.

This matters because Intuitive does not only make money when it sells a robot. Each installed da Vinci system can create ongoing revenue from accessories, instruments, maintenance, and services. That recurring model gives ISRG a powerful long-term advantage.

MDT Offers Value, But Robotics Is Still Developing

Medtronic is a much larger and more diversified healthcare company. It sells products across cardiovascular care, diabetes, neuroscience, surgery, and other medical areas. That makes MDT less dependent on one product category than ISRG.

However, when looking only at surgical robotics, Medtronic is still chasing Intuitive. Hugo has potential, but it has not yet matched da Vinci’s scale, brand recognition, surgeon familiarity, or global procedure volume.

Valuation: ISRG Is More Expensive

The biggest concern for ISRG is valuation. Investors often pay a premium for Intuitive because it has stronger growth, higher robotics leadership, and a proven recurring revenue model. By contrast, MDT usually trades at a lower valuation because its growth profile is slower and more mature.

For conservative investors, MDT may look safer because it is diversified and less expensive. For growth-focused investors, ISRG may still look more attractive because it dominates one of healthcare’s most promising technology markets.

Analyst View: ISRG Appears Better Positioned

The Zacks-linked article topic compares ISRG and MDT as surgical robot stocks. A syndicated version reported that Intuitive Surgical carried a stronger Zacks Rank than Medtronic at the time of publication, with ISRG ranked as a Buy and MDT ranked as a Sell.

That does not guarantee future performance, but it shows that near-term earnings estimate trends appeared more favorable for Intuitive than for Medtronic.

Final Takeaway

ISRG looks like the better surgical robot stock for investors focused on growth, leadership, and long-term robotics adoption. The company has a stronger position in robotic surgery, a proven business model, and a deeper procedure ecosystem.

MDT may still appeal to value and income-focused investors because it is diversified and less expensive. However, as a pure surgical robotics investment, Medtronic has more catching up to do.

Bottom Line

For investors asking which surgical robot stock is the better buy, ISRG appears to have the stronger growth case, while MDT remains the more defensive but slower-moving option.

Disclaimer: This article is for informational purposes only and is not financial advice. Investors should review their own goals, risk tolerance, and professional guidance before buying any stock.

#ISRG #MDT #SurgicalRobotics #MedTechStocks #SlimScan #GrowthStocks #CANSLIM